EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients

Circulating Tumor Cell Clustering Shapes DNA Methylation to Enable Metastasis Seeding

(2019) Sofia Gkountela et al.   CELL

Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models

(2018) Xia Liu et al.   Cancer Discovery

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease

(2018) Annkathrin Hanssen et al.   Cancers

Liquid biopsy on chip: a paradigm shift towards the understanding of cancer metastasis

(2017) Amogha Tadimety et al.   Integrative Biology

Impact of epidermal growth factor receptor gene expression level on clinical outcomes in epidermal growth factor receptor mutant lung adenocarcinoma patients taking first-line epidermal growth factor receptor–tyrosine kinase inhibitors

(2017) Huang-Chih Chang et al.   TUMOR BIOLOGY

Critical issues in the clinical application of liquid biopsy in non-small cell lung cancer

(2017) Mariangela Manicone et al.   Journal of Thoracic Disease

Assessment of common somatic mutations of EGFR, KRAS, BRAF, NRAS in pulmonary non-small cell carcinoma using iPLEX® HS, a new highly sensitive assay for the MassARRAY® System

(2017) Bobbie C. Sutton et al.   PLoS One

Correlation between status of epidermal growth factor receptor mutation and distant metastases of lung adenocarcinoma upon initial diagnosis based on 1063 patients in China

(2016) Hongwei Li et al.   CLINICAL & EXPERIMENTAL METASTASIS

Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy

(2016) C. Alix-Panabieres et al.   Cancer Discovery

Characterization of different CTC subpopulations in non-small cell lung cancer

(2016) Annkathrin Hanssen et al.   Scientific Reports

Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility

(2015) M. Ignatiadis et al.   CLINICAL CANCER RESEARCH

The potential diagnostic power of circulating tumor cell analysis for non-small-cell lung cancer

(2015) Kirsty Ross et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Anti-HER3 monoclonal antibody patritumab sensitizes refractory non-small cell lung cancer to the epidermal growth factor receptor inhibitor erlotinib

(2015) K Yonesaka et al.   ONCOGENE

Contribution of EGFR and ErbB-3 Heterodimerization to the EGFR Mutation-Induced Gefitinib- and Erlotinib-Resistance in Non-Small-Cell Lung Carcinoma Treatments

(2015) Debby D. Wang et al.   PLoS One

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer

(2015) Annkathrin Hanssen et al.   Frontiers in Oncology

Circulating Tumor Cell Clusters Are Oligoclonal Precursors of Breast Cancer Metastasis

(2014) Nicola Aceto et al.   CELL

Biology, detection, and clinical implications of circulating tumor cells

(2014) S. A. Joosse et al.   EMBO Molecular Medicine

Spatial and temporal diversity in genomic instability processes defines lung cancer evolution

(2014) E. C. de Bruin et al.   SCIENCE

Frequent Genetic Alterations in EGFR- and HER2-Driven Pathways in Breast Cancer Brain Metastases

(2013) Ina Hohensee et al.   AMERICAN JOURNAL OF PATHOLOGY

Frequent overexpression of ErbB - receptor family members in brain metastases of non-small cell lung cancer patients

(2013) Anna Sophie Berghoff et al.   APMIS

Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition

(2012) Tobias M Gorges et al.   BMC CANCER

Plasticity of disseminating cancer cells in patients with epithelial malignancies

(2012) Natalia Bednarz-Knoll et al.   CANCER AND METASTASIS REVIEWS

Clinical outcomes in non-small-cell lung cancer patients with EGFR mutations: pooled analysis

(2010) Luis Paz-Ares et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

HER Family Receptor Abnormalities in Lung Cancer Brain Metastases and Corresponding Primary Tumors

(2009) M. Sun et al.   CLINICAL CANCER RESEARCH